Related Experiment Video
Updated: Jun 13, 2025
08:40
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
18.2K
Leveraging current insights on IL-10-producing dendritic cells for developing effective immunotherapeutic approaches.
Konstantina Morali1, Gloria Giacomello1,2, Michela Vuono1,3
1Mechanisms of Peripheral Tolerance Unit, San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.
FEBS Letters
|September 12, 2024
Summary
Tolerogenic dendritic cells (tolDC) are key for immune tolerance. This review highlights how in vitro generated tolDC, particularly those conditioned with IL-10, effectively promote regulatory T cells for therapeutic applications.
Area of Science:
- Immunology
- Cell Biology
- Therapeutic Development
Background:
- Dendritic cells (DC) are crucial antigen-presenting cells regulating immune responses.
- Tolerogenic dendritic cells (tolDC) maintain tissue homeostasis and induce tolerance.
- tolDC are promising for treating immune-mediated conditions.
Purpose of the Study:
- To review current knowledge on tolDC in health and disease.
- To focus on IL-10 conditioning for in vitro tolDC generation.
- To explore molecular, metabolic, and functional profiles of tolDC.
Main Methods:
- Overview of in vitro generation of tolDC from peripheral blood monocytes.
- Focus on IL-10 conditioning as an efficient method.
- Analysis of molecular, metabolic, and functional characteristics.
Main Results:
- IL-10 conditioning is highly effective for generating potent tolDC.
- In vitro generated tolDC modulate T cell dynamics, favoring regulatory T cells (Tregs).
- IL-10-modulated tolDC promote Tregs with strong suppressive activity.
Conclusions:
- tolDC are attractive for re-establishing tolerance in immune-mediated diseases.
- Understanding tolDC pathways is essential for their immunoregulatory functions.
- Further research into tolDC generation and clinical applications is warranted.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
01:24T Cell Types and Functions
961
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
961